论文部分内容阅读
目的:观察分析妈富隆配合诊断性刮宫治疗绝经过渡期功血的临床治疗效果。方法:选择2014年1月~2015年1月在我院进行治疗的60例绝经过渡期功血患者为研究对象,将其随机分为观察组和对照组,每组各30例患者,给予观察组患者采用妈富隆配合诊断性刮宫进行治疗,对照组采用单纯的诊断性刮宫,观察分析2组患者治疗效果,贫血改善程度和子宫内膜厚度以及不良反应等情况。结果:观察组患者的治疗总有效率,贫血改善程度,子宫内膜厚度,显著优予对照组,差异具有统计学意义(P<0.05),2组患者的不良反应发生率差异不具有统计学意义(P>0.05)。结论:采用妈富隆配合诊断性刮宫治疗绝经过渡期功血的治疗效果显著,能够有效的改善患者的子宫内膜厚度和月经量,不良反应发生率低,具有临床推广的应用价值。
Objective: To observe and analyze the clinical effect of Marvelon combined with diagnostic curettage in the treatment of menopausal transitional dysfunction. Methods: Sixty patients with postmenopausal bleeding in our hospital from January 2014 to January 2015 were enrolled in this study. Patients were randomly divided into observation group and control group, 30 patients in each group were given observation The patients were treated with Marvelon with diagnostic curettage, and the control group with simple diagnostic curettage. The therapeutic effect, degree of anemia improvement, endometrial thickness and adverse reactions in the two groups were observed and analyzed. Results: The total effective rate of treatment, the degree of improvement of anemia and endometrial thickness in the observation group were significantly higher than those in the control group (P <0.05). There was no statistical difference in the incidence of adverse reactions between the two groups Significance (P> 0.05). Conclusion: Marvelon combined with diagnostic curettage in the treatment of menopausal transitional dysfunctional uterine bleeding is significant, which can effectively improve the patient’s endometrial thickness and menstrual flow, the incidence of adverse reactions is low, with clinical application value.